Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Viral Cirrhosis”

344 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 344 results

Early research (Phase 1)Study completedNCT01289951
What this trial is testing

Pharmacokinetic Study of Raltegravir in Human Immunodeficiency Virus/Hepatitis C Virus (HIV/VHC) Coinfected Patients With Advanced (Child-Pugh C) Hepatic Cirrhosis

Who this might be right for
Human Immunodeficiency VirusHepatitis C
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal 10
Large-scale testing (Phase 3)Study completedNCT02319031
What this trial is testing

Safety and Efficacy Study of the Combination Daclatasvir (60 mg), Sofosbuvir (400 mg) and Ribavirin (Weight-based Dosing) for 12 or 16 Weeks in Subjects With Genotype 3 Chronic HCV Infection With or Without Prior Treatment Experience and Advanced Fibrosis or Compensated Cirrhosis

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 53
Not applicableUnknownNCT03892681
What this trial is testing

Hepatocyte-specific Versus Extracellular Contrast Agents for Liver MRI: Prospective, Intra-individual Comparison of Diagnostic Performance for Hepatocellular Carcinoma

Who this might be right for
Chronic HepatitisLiver Cirrhosis
Yonsei University 129
Testing effectiveness (Phase 2)Study completedNCT00013702
What this trial is testing

Adefovir Dipivoxil to Treat Hepatitis B in HIV-Infected Patients

Who this might be right for
Hepatitis BHIV Infection
National Institute of Allergy and Infectious Diseases (NIAID) 30
Not applicableStudy completedNCT04352309
What this trial is testing

Efficacy Study Of Oral Glecaprevir/Pibrentasvir Tablet In Pediatric (12 Years and Older) And Adult Treatment-Naive Participants With Chronic Hepatitis C Genotypes 1 To 6 And Liver Cirrhosis

Who this might be right for
Hepatitis C Virus (HCV)
AbbVie 99
Not applicableLooking for participantsNCT07469319
What this trial is testing

Biannual Screening for HCC Offered to Patients With Cirrhosis. Introducing Surveillance for Hepatocellular Carcinoma (HCC) in the Central Denmark Region Using Ultrasound and Alpha-Fetoprotein to Reduce HCC-Related Mortality in Patients With Compensated Non-Viral Cirrhosis

Who this might be right for
Hepatocellular Carcinoma (HCC)Cirrhosis
University of Aarhus 617
Not applicableStudy completedNCT02758509
What this trial is testing

Impact of Antiviral Therapy on Gastroesophageal Varices.

Who this might be right for
Chronic Hepatitis CCirrhosis
Parc de Salut Mar 237
Not applicableStudy completedNCT01537965
What this trial is testing

Evaluation of Innovative Ultrasonic Techniques for Non-invasive Diagnosis of Liver Fibrosis in Patients With Chronic Viral Hepatitis B or C

Who this might be right for
Liver Fibrosis
University Hospital, Grenoble 96
Post-approval studies (Phase 4)Study completedNCT00347009
What this trial is testing

Adefovir Dipivoxil For The Treatment Of Patients With Chronic Hepatitis B Related Advanced Fibrosis Or Cirrhosis

Who this might be right for
Hepatitis B, ChronicCirrhosisFibrosis+1 more
GlaxoSmithKline 155
Not applicableStudy completedNCT01082419
What this trial is testing

Acoustic Radiation Force Impulse Imaging (ARFI) : a New Technique to Assess Liver Elasticity

Who this might be right for
Liver FibrosisLiver CirrhosisViral Hepatitis+3 more
University Hospital, Bordeaux 109
Large-scale testing (Phase 3)Study completedNCT02216422
What this trial is testing

Evaluate Chronic Hepatitis C Virus (HCV) Infection in Cirrhotic Adults With Genotype 1b (GT1b) Infection

Who this might be right for
Chronic Hepatitis C Virus (HCV) Infection
AbbVie 36
Not applicableUnknownNCT04797910
What this trial is testing

Effect of Antiviral Therapy on HVPG in Patients With Viral Cirrhosis

Who this might be right for
Portal Hypertension
Nanfang Hospital, Southern Medical University 24
Not applicableUnknownNCT03775798
What this trial is testing

Incidence of de Novo Hepatocellular Carcinoma After Antiviral Agents for HCV.

Who this might be right for
Hepatitis CCirrhosisAntiviral Drug Adverse Reaction
Austral University, Argentina 2,200
Large-scale testing (Phase 3)Study completedNCT02219503
What this trial is testing

Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis

Who this might be right for
Chronic Hepatitis C InfectionCompensated Cirrhosis
AbbVie 60
Not applicableStudy completedNCT00252642
What this trial is testing

Peginterferon Alpha-2a Maintenance Therapy for Portal Hypertension in Patients With Hepatitis C

Who this might be right for
Hepatitis CCirrhosisFibrosis
Virginia Commonwealth University 60
Post-approval studies (Phase 4)UnknownNCT04939441
What this trial is testing

Regression of Liver Fibrosis by Tenofovir Alafenamide (TAF)

Who this might be right for
Chronic Hepatitis B
Jidong Jia 100
Not applicableUnknownNCT03456440
What this trial is testing

The Use of MRI Apparent Diffusion Coefficient Value (ADC Value) to Assess Liver Cirrhosis

Who this might be right for
Hepatitis C
Assiut University 30
Not applicableUnknownNCT00160940
What this trial is testing

Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis

Who this might be right for
Hepatitis CHepatitis BAutoimmune Hepatitis+2 more
University Health Network, Toronto 200
Large-scale testing (Phase 3)Study completedNCT04112303
What this trial is testing

Study to Investigate the Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed-Dose Combination for 12 Weeks in Adults With Chronic HCV Infection and Compensated Cirrhosis

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 37
Large-scale testing (Phase 3)Study completedNCT02201901
What this trial is testing

Sofosbuvir/Velpatasvir Fixed-Dose Combination in Adults With Chronic HCV Infection and Child-Pugh Class B Cirrhosis

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 268
Load More Results